The Role of the 3′UTR Region in the Regulation of the ACVR1/Alk-2 Gene Expression

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Mura, Marzia ^a   Cappato, Serena ^b   Giacopelli, Francesca ^b   Ravazzolo, Roberto ^a,b   Bocciardi, Renata ^a,b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; MESSENGER RNA; MICRORNA; MICRORNA 148B; MICRORNA 26A; MICRORNA 365; UNCLASSIFIED DRUG; ACTIVIN RECEPTOR 1; ACVR1 PROTEIN, HUMAN; ACVR1 PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ACVR1 GENE; ALK 2 GENE; ARTICLE; BINDING SITE; BIOINFORMATICS; COMPUTER ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; POSTTRANSCRIPTIONAL CONTROL; PREDICTION; ANIMAL; CELL LINE; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; MUTAGENESIS; NUCLEOTIDE SEQUENCE; REPORTER GENE;

3' UNTRANSLATED REGIONS; ACTIVIN RECEPTORS, TYPE I; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; DACTINOMYCIN; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; RNA, MESSENGER;

EID: 84870814111     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050958     Document Type: Article

References (36)

1. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions.Cell. 136(2): 215-233.
2. Miyazono K, Kamiya Y, Morikawa M, (2010) Bone morphogenetic protein receptors and signal transduction.J Biochem. 147(1): 35-51.
3. Wang J, Greene SB, Martin JF, (2011) BMP signaling in congenital heart disease: new developments and future directions. Birth Defects Res A Clin Mol Teratol. 91(6): 441-448.
4. Harradine KA, Akhurst RJ, (2006) Mutations of TGFbeta signaling molecules in human disease. Ann Med. 38(6): 403-414.
5. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, et al. (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 38(5): 525-527.
6. Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, et al. (2009) Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat. 30(3): 379-390.
7. Luzi E, Marini F, Sala SC, Tognarini I, Galli G, et al. (2008) Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res. 23(2): 287-295.
8. Altus MS, Nagamine Y, (1991) Protein synthesis inhibition stabilizes urokinase-typeplasminogen activator mRNA. Studies in vivo and in cell-free decay reactions. J Biol Chem. Nov 5 266(31): 21190-21196.
9. Yamazaki S, Takeshige K, (2008) Protein synthesis inhibitors enhance the expression of mRNAs for early inducible inflammatory genes via mRNA stabilization. Biochim Biophys Acta. Feb 1779(2): 108-114.
10. Sayed D, Abdellatif M, (2011) MicroRNAs in development and disease. Physiol Rev. 91(3): 827-87.
11. Dudas M, Sridurongrit S, Nagy A, Okazaki K, Kaartinen V, (2004) Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells.Mech Dev. 121(2): 173-182.
12. Kaartinen V, Dudas M, Nagy A, Sridurongrit S, Lu MM, et al. (2004) Cardiac outflow tract defects in mice lacking ALK2 in neural crest cells. Development 131(14): 3481-3490.
13. de Sousa Lopes SM, Roelen BA, Monteiro RM, Emmens R, Lin HY, et al. (2004) BMP signaling mediated by ALK2 in the visceral endoderm is necessary for the generation of primordial germ cells in the mouse embryo. Genes Dev. 18(15): 1838-1849.
14. Wang J, Sridurongrit S, Dudas M, Thomas P, Nagy A, et al. (2005) Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart. Dev Biol. 286(1): 299-310.
15. Luo J, Tang M, Huang J, He BC, Gao JL, et al. (2010) TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells.J Biol Chem. 285(38): 29588-29598.
16. Romero D, Terzic A, Conley BA, Craft CS, Jovanovic B, et al. (2010) Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration.Carcinogenesis. 31(3): 359-366.
17. Herrera B, van Dinther M, Ten Dijke P, Inman GJ, (2009) Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation. Cancer Res. 69(24): 9254-9262.
18. Shore EM, Kaplan FS, (2010) Inherited human diseases of heterotopic bone formation.Nat Rev Rheumatol. 6(9): 518-527.
19. Karbiener M, Neuhold C, Opriessnig P, Prokesch A, Bogner-Strauss JG, et al. (2011) MicroRNA-30c promotes human adipocyte differentiation and co-represses PAI-1 and ALK2. RNA Biol. 1;8(5).
20. Liu X, Zhan Z, Xu L, Ma F, Li D, et al. (2010) MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKII. J Immunol 185(12): 7244-7251.
21. Schoolmeesters A, Eklund T, Leake D, Vermeulen A, Smith Q, et al (2009) Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells.PLoS One. 4(5): e5605.
22. Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, et al. (2011) MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.Mol Cancer. 4 10: 1.
23. Song Y, Xu Y, Wang Z, Chen Y, Yue Z, et al. (2011) MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer. Int J Cancer. Oct 23 doi: 10.1002/ijc.26485.
24. Maes OC, Sarojini H, Wang E, (2009) Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. J Cell Physiol. 221(1): 109-119.
25. Qin B, Xiao B, Liang D, Xia J, Li Y, et al. (2011) MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression. Biochem Biophys Res Commun. 410(1): 127-133.
26. Sun L, Xie H, Mori MA, Alexander R, Yuan B, et al. (2011) Mir193b-365 is essential for brown fat differentiation. Nat Cell Biol. 13(8): 958-965.
27. Guan YJ, Yang X, Wei L, Chen Q, (2011) MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4. FASEB J. 25(12): 4457-4466.
28. Xu Z, Xiao SB, Xu P, Xie Q, Cao L, et al. (2011) miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB. J Biol Chem. 286(24): 21401-21412.
29. Zhang B, Liu XX, He JR, Zhou CX, Guo M, et al. (2011) Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis. 32(1): 2-9.
30. Lu J, He ML, Wang L, Chen Y, Liu X, et al. (2011) MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res. 71(1): 225-233.
31. Chen L, Zheng J, Zhang Y, Yang L, Wang J, et al. (2011) Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and-independent pathways. Mol Ther. 19(8): 1521-1528.
32. Witwer KW, Sisk JM, Gama L, Clements JE, (2010) MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response. J Immunol. 184(5): 2369-2376.
33. Vasudevan S, Steitz JA, (2007) AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell. 128(6): 1105-1118.
34. Vasudevan S, Tong Y, Steitz JA, (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007 318(5858): 1931-1934.
35. Khabar KS, (2010) Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell Mol Life Sci. 67(17): 2937-2955.
36. Betel D, Koppal A, Agius P, Sander C, Leslie C, (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites.Genome Biol. 11(8): R90.